{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:22:52Z","timestamp":1790097772135,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116462","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T17:06:53Z","timestamp":1710954413000},"page":"116462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating \u03b12-adrenoceptor: A combined randomised animal and in vitro study"],"prefix":"10.1016","volume":"174","author":[{"given":"Qizhe","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enqiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2024.116462_bib1","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.biopha.2024.116462_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41581-020-0268-7","article-title":"The impact of chronic kidney disease on global health","volume":"16","author":"Carney","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116462_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0306-9877(95)90221-X","article-title":"Fibrosis causes progressive kidney failure","volume":"45","author":"Cohen","year":"1995","journal-title":"Med. Hypotheses"},{"issue":"11","key":"10.1016\/j.biopha.2024.116462_bib4","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1681\/ASN.2006050420","article-title":"Renal fibroblasts and myofibroblasts in chronic kidney disease","volume":"17","author":"Strutz","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2024.116462_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.569322","article-title":"New insights into the role and mechanism of partial epithelial-mesenchymal transition in kidney fibrosis","volume":"11","author":"Sheng","year":"2020","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116462_bib6","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1046\/j.1523-1755.1999.00656.x","article-title":"Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro.","volume":"56","author":"Fan","year":"1999","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.biopha.2024.116462_bib7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nm.3901","article-title":"Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease","volume":"21","author":"Grande","year":"2015","journal-title":"Nat. Med"},{"issue":"4","key":"10.1016\/j.biopha.2024.116462_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semnephrol.2016.05.005","article-title":"The role of acute kidney injury in chronic kidney disease","volume":"36","author":"Hsu","year":"2016","journal-title":"Semin Nephrol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116462_bib9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","article-title":"Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment","volume":"96","author":"Peerapornratana","year":"2019","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.biopha.2024.116462_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7120554","article-title":"One--year progression and risk factors for the development of chronic kidney disease in septic shock patients with acute kidney injury: a single-centre retrospective Cohort study.","volume":"7","author":"Kim","year":"2018","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.biopha.2024.116462_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nri3743","article-title":"Regulated cell death and inflammation: an auto-amplification loop causes organ failure","volume":"14","author":"Linkermann","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116462_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41418-018-0172-x","article-title":"Necroptosis in anti-viral inflammation","volume":"26","author":"Nailwal","year":"2019","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.biopha.2024.116462_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41419-019-1416-5","article-title":"Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.116462_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10557-019-06857-1","article-title":"Dexmedetomidine preconditioning protects cardiomyocytes against hypoxia\/reoxygenation-induced necroptosis by inhibiting HMGB1-mediated inflammation","volume":"33","author":"Chen","year":"2019","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2024.116462_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106768","article-title":"Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats","volume":"86","author":"Zhong","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.116462_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2017.12.008","article-title":"The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4\/NF-\u03baB and PI3K\/Akt\/mTOR pathways","volume":"94","author":"Meng","year":"2018","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116462_bib17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jss.2012.07.017","article-title":"Dexmedetomidine inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated macrophages In vitro","volume":"181","author":"Chang","year":"2013","journal-title":"J. Surg. Res."},{"issue":"3","key":"10.1016\/j.biopha.2024.116462_bib18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00134-009-1704-0","article-title":"The impact of crystalloid and colloid infusion on the kidney in rodent sepsis","volume":"36","author":"Schick","year":"2010","journal-title":"Intensive care Med."},{"issue":"4","key":"10.1016\/j.biopha.2024.116462_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2024.116462_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/ilar.43.4.244","article-title":"Guidelines for the design and statistical analysis of experiments using laboratory animals","volume":"43","author":"Festing","year":"2002","journal-title":"ILAR J."},{"issue":"1","key":"10.1016\/j.biopha.2024.116462_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ilar.47.1.5","article-title":"Design and statistical methods in studies using animal models of development","volume":"47","author":"Festing","year":"2006","journal-title":"Ilar J."},{"issue":"9","key":"10.1016\/j.biopha.2024.116462_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1369\/0022155419849388","article-title":"Extracellular matrix in kidney fibrosis: more than just a Scaffold","volume":"67","author":"B\u00fclow","year":"2019","journal-title":"J. Histochem. Cytochem."},{"issue":"5","key":"10.1016\/j.biopha.2024.116462_bib23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.kint.2017.06.030","article-title":"AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms","volume":"92","author":"He","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.biopha.2024.116462_bib24","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1038\/ki.2010.418","article-title":"Mechanistic connection between inflammation and fibrosis","volume":"119","author":"Lee","year":"2010","journal-title":"Kidney Int Suppl."},{"issue":"3","key":"10.1016\/j.biopha.2024.116462_bib25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1681\/ASN.2010040430","article-title":"Dangers within: DAMP responses to damage and cell death in kidney disease","volume":"22","author":"Rosin","year":"2011","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"key":"10.1016\/j.biopha.2024.116462_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108868","article-title":"Coenzyme Q10 attenuates renal fibrosis by inhibiting RIP1-RIP3-MLKL-mediated necroinflammation via Wnt3\u03b1\/\u03b2-catenin\/GSK-3\u03b2 signaling in unilateral ureteral obstruction","volume":"108","author":"Jiang","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116462_bib27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41419-018-0936-8","article-title":"RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2024.116462_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2018.05.003","article-title":"Dexmedetomidine attenuates renal fibrosis via \u03b12-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia\/reperfusion","volume":"207","author":"Li","year":"2018","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116462_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.15586\/aei.v50i2.505","article-title":"Dexmedetomidine represses TGF-\u03b21-induced extracellular matrix production and proliferation of airway smooth muscle cells by inhibiting MAPK signaling pathway","volume":"50","author":"Zhou","year":"2022","journal-title":"Allergol. Et. Immunopathol."},{"issue":"22","key":"10.1016\/j.biopha.2024.116462_bib30","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biopha.2024.116462_bib31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"17","key":"10.1016\/j.biopha.2024.116462_bib32","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1093\/emboj\/cdg438","article-title":"JNK-interacting protein 3 associates with Toll-like receptor 4 and is involved in LPS-mediated JNK activation","volume":"22","author":"Matsuguchi","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2024.116462_bib33","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3389\/fphys.2017.00829","article-title":"The JNK signaling pathway in renal fibrosis","volume":"8","author":"Grynberg","year":"2017","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116462_bib34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1165\/rcmb.2009-0282OC","article-title":"c-Jun N-terminal kinase 1 promotes transforming growth factor-\u03b21-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3","volume":"44","author":"Velden","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2024.116462_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresbull.2014.07.001","article-title":"Both JNK and P38 MAPK pathways participate in the protection by dexmedetomidine against isoflurane-induced neuroapoptosis in the hippocampus of neonatal rats","volume":"107","author":"Liao","year":"2014","journal-title":"Brain Res. Bull."},{"issue":"6","key":"10.1016\/j.biopha.2024.116462_bib36","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s10753-019-01082-2","article-title":"Role of JNK signaling pathway in dexmedetomidine post-conditioning-induced reduction of the inflammatory response and autophagy effect of focal cerebral ischemia reperfusion injury in rats","volume":"42","author":"Zhu","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2024.116462_bib37","article-title":"Dexmedetomidine ameliorates acute stress-induced kidney injury by attenuating oxidative stress and apoptosis through inhibition of the ROS\/JNK signaling pathway","volume":"2018","author":"Chen","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.biopha.2024.116462_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3892\/mmr.2013.1867","article-title":"Effect of dexmedetomidine on lung ischemia\u2011reperfusion injury","volume":"9","author":"Jiang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2024.116462_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105898","article-title":"Dexmedetomidine-mediated protection against septic liver injury depends on TLR4\/MyD88\/NF-\u03baB signaling downregulation partly via cholinergic anti-inflammatory mechanisms","volume":"76","author":"Zi","year":"2019","journal-title":"Int. Immunopharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T22:53:08Z","timestamp":1782341588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224003469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":39,"alternative-id":["S0753332224003469"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116462","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating \u03b12-adrenoceptor: A combined randomised animal and in vitro study","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116462"}}